Why It Matters
The American College of Clinical Pharmacy (ACCP) filed its second quarter 2026 lobbying disclosure, reporting $144,981 in lobbying expenses, reflecting continued federal advocacy on pharmacy policy and medication safety. ACCP's June advocacy newsletter shows the organization's current priorities center on establishing Medicare coverage for clinical pharmacy services and protecting federal funding for pharmacy residency programs.
Broader Context
John McGlew serves as senior director of government affairs for the ACCP, a role he has held since at least 2017. His lobbying work covers pharmacy practice, Medicare and Medicaid, health and medication safety, education, and medical research. Kathy Pham, senior director of policy and professional affairs, has been registered as a lobbyist for the organization since at least 2019 and focuses on the same issue areas.
ACCP's March 26 advocacy day on Capitol Hill held focused lobbying visits on establishing Medicare coverage for comprehensive clinical pharmacy services as part of broader Medicare payment reform, and on urging cosponsorship of legislation to protect federal funding for pharmacy and nursing residency programs. That bill, the Rebuilding America's Health Care Schools Act of 2025 (S. 1087, H.R. 1708), is led in Congress by Sens. Amy Klobuchar (D-MN) and Thom Tillis (R-NC) and Reps. Darrin LaHood (R-IL) and Michelle Fischbach (R-MN). It would require the Centers for Medicare and Medicaid Services to cover the full direct and indirect costs of training nursing and allied health education participants, including pharmacy residents, at hospitals that operate residency programs.
ACCP submitted comments to the House Energy and Commerce Committee's Subcommittee on Health following its Wednesday, February 11, hearing on the prescription drug supply chain, urging Congress to focus on the value of medication therapy rather than drug cost alone and calling for a defined clinical pharmacy benefit under Medicare. The organization is also working with the GOP Doctors Caucus in Congress and has engaged the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, submitting comments following its March 18 meeting.
The Bottom Line
ACCP's quarter two filing points to a lobbying agenda anchored in Medicare payment policy and pharmacy workforce funding, with the group's advocacy day and committee comments signaling where its lobbying efforts are headed next.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article